The company is also developing antibody screening, genotyping and phenotyping products, software for genotyping applications, transplant monitoring, and platforms for clinical laboratories, research centers and point-of-care customers. In addition, Biofortuna Ltd. provides genotyping and custom assay development services.
Biofortuna have a range of unique HLA* diagnostic solutions which will address:
- Transplantation
- Blood grouping
- Disease identification
- Pharmacogenetics